302 related articles for article (PubMed ID: 36838987)
1. Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases.
Padilla A; Manganaro JF; Huesgen L; Roess DA; Brown MA; Crans DC
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838987
[TBL] [Abstract][Full Text] [Related]
2. Structure of human lysine methyltransferase Smyd2 reveals insights into the substrate divergence in Smyd proteins.
Xu S; Zhong C; Zhang T; Ding J
J Mol Cell Biol; 2011 Oct; 3(5):293-300. PubMed ID: 21724641
[TBL] [Abstract][Full Text] [Related]
3. Functions of SMYD proteins in biological processes: What do we know? An updated review.
Rueda-Robles A; Audano M; Álvarez-Mercado AI; Rubio-Tomás T
Arch Biochem Biophys; 2021 Nov; 712():109040. PubMed ID: 34555372
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of SET and MYND domain-containing proteins.
Spellmon N; Holcomb J; Trescott L; Sirinupong N; Yang Z
Int J Mol Sci; 2015 Jan; 16(1):1406-28. PubMed ID: 25580534
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis.
Song J; Liu Y; Chen Q; Yang J; Jiang Z; Zhang H; Liu Z; Jin B
Oncol Lett; 2019 Apr; 17(4):3851-3861. PubMed ID: 30930987
[TBL] [Abstract][Full Text] [Related]
6. The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization.
Dashti P; van de Peppel J; Thaler R; Paradise CR; Stein GS; Montecino MA; van Leeuwen JPTM; van der Eerden BJ; Dudakovic A; van Wijnen AJ
Gene; 2023 Jan; 851():146928. PubMed ID: 36191822
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2.
Abu-Farha M; Lanouette S; Elisma F; Tremblay V; Butson J; Figeys D; Couture JF
J Mol Cell Biol; 2011 Oct; 3(5):301-8. PubMed ID: 22028380
[TBL] [Abstract][Full Text] [Related]
8. The SMYD family proteins in immunology: An update of their obvious and non-obvious relations with the immune system.
Rubio-Tomás T
Heliyon; 2021 Jun; 7(6):e07387. PubMed ID: 34235289
[TBL] [Abstract][Full Text] [Related]
9. Histone methyltransferase SMYD2: ubiquitous regulator of disease.
Yi X; Jiang XJ; Fang ZM
Clin Epigenetics; 2019 Aug; 11(1):112. PubMed ID: 31370883
[TBL] [Abstract][Full Text] [Related]
10. Lysine methyltransferase Smyd2 regulates Hsp90-mediated protection of the sarcomeric titin springs and cardiac function.
Voelkel T; Andresen C; Unger A; Just S; Rottbauer W; Linke WA
Biochim Biophys Acta; 2013 Apr; 1833(4):812-22. PubMed ID: 23047121
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of the Value of SMYD Family Members in the Prognosis and Immune Infiltration of Malignant Digestive System Tumors.
Liu D; Wang X; Shi E; Wang L; Nie M; Li L; Jiang Q; Kong P; Shi S; Wang C; Yan S; Qin Z; Zhao S
Front Genet; 2021; 12():699910. PubMed ID: 34335697
[TBL] [Abstract][Full Text] [Related]
12. The Smyd Family of Methyltransferases: Role in Cardiac and Skeletal Muscle Physiology and Pathology.
Tracy C; Warren JS; Szulik M; Wang L; Garcia J; Makaju A; Russell K; Miller M; Franklin S
Curr Opin Physiol; 2018 Feb; 1():140-152. PubMed ID: 29435515
[TBL] [Abstract][Full Text] [Related]
13. Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications.
Rubio-Tomás T
Mol Biol Rep; 2021 Nov; 48(11):7499-7508. PubMed ID: 34510321
[TBL] [Abstract][Full Text] [Related]
14. SMYD proteins: key regulators in skeletal and cardiac muscle development and function.
Du SJ; Tan X; Zhang J
Anat Rec (Hoboken); 2014 Sep; 297(9):1650-62. PubMed ID: 25125178
[TBL] [Abstract][Full Text] [Related]
15. Structure based functional annotation of a MYND-less lysine methyl transferase in
Dey J; Kishore Prasad H
Bioinformation; 2022; 18(12):1146-1153. PubMed ID: 37701516
[No Abstract] [Full Text] [Related]
16. SMYD Family Members Serve as Potential Prognostic Markers and Correlate with Immune Infiltrates in Gastric Cancer.
Liu D; Liu M; Wang W; Li X; Shi E; Zhang C; Wang Y; Zhang Y; Wang L; Wang X
J Oncol; 2023; 2023():6032864. PubMed ID: 36816359
[TBL] [Abstract][Full Text] [Related]
17. Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.
Patani N; Jiang WG; Newbold RF; Mokbel K
Anticancer Res; 2011 Dec; 31(12):4115-25. PubMed ID: 22199269
[TBL] [Abstract][Full Text] [Related]
18. Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation.
Zhu L; Brown MA; Sims RJ; Tiwari GR; Nie H; Mayfield RD; Tucker HO
Cells; 2023 Jun; 12(13):. PubMed ID: 37443729
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of histone and p53 methyltransferase SmyD2 reveal a conformational flexibility of the autoinhibitory C-terminal domain.
Jiang Y; Sirinupong N; Brunzelle J; Yang Z
PLoS One; 2011; 6(6):e21640. PubMed ID: 21738746
[TBL] [Abstract][Full Text] [Related]
20. Function of the MYND Domain and C-Terminal Region in Regulating the Subcellular Localization and Catalytic Activity of the SMYD Family Lysine Methyltransferase Set5.
Jaiswal D; Turniansky R; Moresco JJ; Ikram S; Ramaprasad G; Akinwole A; Wolf J; Yates JR; Green EM
Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31685550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
